Stacey GandlerBrand Nourishment
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Paul TheisenPatient Acquisition
Daniel SontupeMarket Access
Frank BurrellScientific Storytelling
Suma Ramadas, PhDMedical Affairs
Liz KaneImpactful Strategy
Amy GilesIncreasing Engagement
Matthew DurhamOmnidynamic Marketing
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
Xolair® (omalizumab), indicated as add-on therapy for the treatment of chronic spontaneous urticaria (CSU)[1], ...
Study successfully achieved both primary endpoints Second positive Phase 3 demonstrating the safety and ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email